Role of HLA class-I antigen peptide loading complex components in immune evasion and treatment sensitivity in human lung cancer.

Authors

null

Adrien Costantini

Yale University, New Haven, CT

Adrien Costantini , Kishu Ranjan , Soldano Ferrone , Kurt A. Schalper

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics—Immunotherapy

Sub Track

Tissue-Based Biomarkers

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 2623)

DOI

10.1200/JCO.2023.41.16_suppl.2623

Abstract #

2623

Poster Bd #

465

Abstract Disclosures

Similar Posters

First Author: Elio Adib

First Author: Andreas Nicholas Saltos

Poster

2018 ASCO-SITC Clinical Immuno-Oncology Symposium

Efficacy of immune-checkpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC) patients harboring activating molecular alterations.

Efficacy of immune-checkpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC) patients harboring activating molecular alterations.

First Author: Laurent Mhanna

First Author: Ross A. Soo